Faculty

Sara Keller, MD, VOCCME Faculty 2025

Sara Keller, MD, MPH, MSHP

Dr. Sara Keller graduated from the Duke University School of Medicine in Durham, North Carolina, in 2007. She completed her Masters in Public Health in Epidemiology in 2006 at the University of North Carolina at Chapel Hill. Dr. Keller then completed her residency in Internal Medicine in the Oster Medical Residency Training Program at the Johns Hopkins Hospital in Baltimore, Maryland, in 2010. Dr. Keller then completed her fellowship in Infectious Diseases, Healthcare Improvement and Patient Safety in 2013 at the Centers for Healthcare Improvement and Patient Safety, Hospital of the University of Pennsylvania, in Philadelphia. She also completed a Master of Science in Health Policy at the University of Pennsylvania in Philadelphia in 2013. 

Dr. Keller is an Associate Professor in the Division of Infectious Diseases, Department of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland. She has joint appointments in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health and the Armstrong Institute for Patient Safety and Quality at the Johns Hopkins Bloomberg School of Public Health. Dr. Keller also directs the Johns Hopkins Internal Medicine Residency Program’s Patient Safety and Quality Improvement Pathway. Dr. Keller is a practicing infectious diseases physician. Dr. Keller is board-certified in Internal Medicine and Infectious Disease by the American Board of Internal Medicine. 

Dr. Keller’s research interests include healthcare-associated infection prevention in home settings, outpatient parenteral antimicrobial therapy, and improving antibiotic stewardship, particularly in ambulatory and telehealth settings. She has led national collaboratives focusing on improving appropriate antibiotic use in primary care, urgent care settings, and telemedicine settings. Her primary research focus is on improving the quality of care and patient safety among patients being discharged from the hospital on intravenous antimicrobials or with venous catheters in the home. 

Dr. Keller is a member of the Infectious Disease Society of America and the Society of Healthcare Epidemiology of America. In 2023, the Society for Healthcare Epidemiology of America named her a Super Advocate. Dr. Keller became a fellow of the Infectious Disease Society of America in 2022. 

Dr. Keller discloses she was a consultant for Pfizer. All relevant financial relationships have been mitigated.